Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001047033 | SCV001210965 | pathogenic | not provided | 2025-01-12 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 938 of the ABCA4 protein (p.Phe938Ser). This variant is present in population databases (rs149071415, gnomAD 0.05%). This missense change has been observed in individuals with ABCA4-related conditions (PMID: 28041643, 29925512; internal data). ClinVar contains an entry for this variant (Variation ID: 438091). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV000504891 | SCV001240414 | pathogenic | Retinal dystrophy | 2019-07-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001047033 | SCV001763949 | uncertain significance | not provided | 2020-01-07 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32581362, 29925512, 28041643) |
Fulgent Genetics, |
RCV005034047 | SCV005659505 | likely pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-02-13 | criteria provided, single submitter | clinical testing | |
NIHR Bioresource Rare Diseases, |
RCV000504891 | SCV000598953 | likely pathogenic | Retinal dystrophy | 2015-01-01 | no assertion criteria provided | research |